Critically Important Antimicrobials for Human Medicine : 5th Revision

Ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use

Overview

The WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) reviews and updates the WHO list of critically important antimicrobials for human medicine in every two years. This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.

 

WHO CIA publications

Critically Important Antimicrobials for Human Medicine

Critically Important Antibacterial Agents for Human Medicine for Risk Management Strategies of Non-Human Use

Critically Important Antimicrobials for Human Medicine : 2nd Revision

Critically Important Antimicrobials for Human Medicine : 3rd Revision

Critically Important Antimicrobials for Human Medicine : 4th Revision

Critically Important Antimicrobials for Human Medicine : 6th Revision


WHO Team
Antimicrobial Resistance Division (AMR), Global Coordination and Partnership (GCP)
Number of pages
48
Reference numbers
ISBN: 9789241512220
Copyright